MetaCap

Guardian Pharmacy Services Insider Trades

NYSE: GRDNConsumer StaplesRetail-Drug Stores and Proprietary StoresUSD

41.28-0.32 (-0.77%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
10 · $419.26M
Shares bought / sold
0 / 14.12M
Net activity
Net selling $419.3 million

Guardian Pharmacy Services insider activity

Over the last 12 months, Guardian Pharmacy Services insiders reported 42 transactions on SEC Form 4: 0 open-market purchases and 10 sales. Insiders bought $0 and sold $419.3 million worth of stock, for net insider selling of $419.3 million. The largest seller was Bindley Capital Partners I, LLC, with $106.0 million in reported sales.

The most recent filing shows Mudd William Franklin (See Remarks) reporting a transaction in 38,282 shares on Sep 27, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GRDN's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

GRDN insider transactions

Guardian Pharmacy Services insider transactions
DateInsiderTypeSharesValueFiling
Sep 27, 2026Towns DouglasSee RemarksOption exercise23,450—Form 4
Sep 27, 2026Bindley Capital Partners I, LLC10% OwnerOption exercise6,100,175—Form 4
Sep 27, 2026Cardinal Equity Fund, L.P.Member of 10% owner GroupOption exercise471,057—Form 4
Sep 27, 2026Eakins RichardSenior Vice President, SalesOption exercise36,052—Form 4
Sep 27, 2026Crisafulli ChrisSee RemarksOption exercise18,931—Form 4
Sep 27, 2026Morris David KSee RemarksOption exercise641,870—Form 4
Sep 27, 2026BINDLEY WILLIAM EDirectorOption exercise6,100,175—Form 4
Sep 27, 2026Burke FredSee RemarksOption exercise1,298,825—Form 4
Sep 27, 2026Pharmacy Investors, LLCMember of 10% Owner GroupOption exercise1,413,939—Form 4
Sep 27, 2026Martin David NormanSee RemarksOption exercise39,865—Form 4
Sep 27, 2026Forbes KendallMember of 10% Owner GroupOption exercise608,570—Form 4
Sep 27, 2026Tuch JeffreySee RemarksOption exercise55,578—Form 4
Sep 27, 2026Salentine Thomas J JrDirectorOption exercise6,100,175—Form 4
Sep 27, 2026Ackerman JohnDirectorOption exercise471,057—Form 4
Sep 27, 2026Ackerman JohnDirectorOption exercise1,413,939—Form 4
Sep 27, 2026Weir RobertSee RemarksOption exercise23,450—Form 4
Sep 27, 2026Mudd William FranklinSee RemarksOption exercise38,282—Form 4
May 5, 2026LEWIS RANDALL JDirectorAward4,028—Form 4
May 5, 2026Patchett Mary SueDirectorAward4,028—Form 4
May 5, 2026COSLER STEVEN DDirectorAward4,028—Form 4
Mar 28, 2026Bindley Capital Partners I, LLC10% OwnerOption exercise6,100,175—Form 4
Mar 28, 2026Morris David KSee RemarksOption exercise641,869—Form 4
Mar 28, 2026Ackerman JohnDirectorOption exercise471,057—Form 4
Mar 28, 2026Ackerman JohnDirectorOption exercise1,413,939—Form 4
Mar 28, 2026Burke FredSee RemarksOption exercise1,298,826—Form 4
Mar 28, 2026Pharmacy Investors, LLCMember of 10% owner groupOption exercise1,413,939—Form 4
Mar 28, 2026Salentine Thomas J JrDirectorOption exercise6,100,175—Form 4
Mar 28, 2026Cardinal Equity Fund, L.P.Member of 10% owner groupOption exercise471,057—Form 4
Mar 28, 2026Forbes KendallSee RemarksOption exercise608,570—Form 4
Mar 28, 2026BINDLEY WILLIAM EDirectorOption exercise6,100,175—Form 4
Mar 20, 2026Ackerman JohnDirectorSale275,728$8.18MForm 4
Mar 20, 2026Ackerman JohnDirectorSale827,636$24.57MForm 4
Mar 20, 2026Bindley Capital Partners I, LLC10% OwnerSale3,570,677$105.99MForm 4
Mar 20, 2026BINDLEY WILLIAM EDirectorSale3,570,677$105.99MForm 4
Mar 20, 2026Salentine Thomas J JrDirectorSale3,570,677$105.99MForm 4
Mar 20, 2026Cardinal Equity Fund, L.P.Member of 10% owner groupSale275,728$8.18MForm 4
Mar 20, 2026Pharmacy Investors, LLCMember of 10% owner groupSale827,636$24.57MForm 4
Mar 20, 2026Forbes KendallSee RemarksSale346,672$10.29MForm 4
Mar 20, 2026Burke FredSee RemarksSale671,432$19.93MForm 4
Mar 20, 2026Morris David KSee RemarksSale187,855$5.58MForm 4
Mar 1, 2026Forbes KendallSee RemarksAward8,952—Form 4
Mar 1, 2026Morris David KSee RemarksAward8,952—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related